Reviva Pharmaceuticals (RVPH) Stock Chart & Stock Price History → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free RVPH Stock Alerts $1.87 -0.27 (-12.62%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Reviva Pharmaceuticals Stock Price Performance5 Day Performance-41.56%1 Month Performance-49.18%3 Month Performance-57.50%6 Month Performance-67.48%Year-To-Date Performance-63.69%1 Year Performance-77.97% Receive RVPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. RVPH Stock Chart for Saturday, May, 11, 2024 RVPH Chart by TradingView Reviva Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$2.14$1.87-12.62%$2.17$1.82718,418 shs$52.21 million05/09/2024$2.82$2.14-24.11%$2.94$2.081.22 million shs$59.75 million05/08/2024$2.80$2.82+0.71%$3.18$2.80236,498 shs$78.73 million05/07/2024$2.94$2.80-4.76%$3.05$2.80181,316 shs$78.18 million05/06/2024$3.20$2.94-8.13%$3.20$2.94207,588 shs$82.08 million05/03/2024$3.18$3.20+0.63%$3.27$3.11109,318 shs$89.34 million Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$3.26$3.18-2.45%$3.30$3.1489,051 shs$88.79 million05/01/2024$3.06$3.26+6.54%$3.29$3.0678,760 shs$91.02 million04/30/2024$2.90$3.06+5.52%$3.15$2.90112,978 shs$85.44 million04/29/2024$2.99$2.90-3.01%$3.07$2.90114,300 shs$80.97 million04/26/2024$2.98$2.99+0.34%$3.08$2.94115,227 shs$83.48 million04/25/2024$3.02$2.98-1.32%$3.10$2.90107,136 shs$83.20 million04/24/2024$3.06$3.02-1.31%$3.13$2.9077,687 shs$84.32 million04/23/2024$3.09$3.06-0.97%$3.19$3.0177,792 shs$85.44 million04/22/2024$3.02$3.09+2.32%$3.15$2.95111,561 shs$86.27 million04/19/2024$3.02$3.02$3.08$2.95139,500 shs$84.32 million04/18/2024$3.20$3.02-5.63%$3.20$2.98125,372 shs$84.32 million04/17/2024$3.33$3.20-3.90%$3.35$3.1798,296 shs$89.34 million04/16/2024$3.48$3.33-4.31%$3.42$3.2793,440 shs$92.97 million04/15/2024$3.69$3.48-5.69%$3.60$3.00733,778 shs$97.16 million04/12/2024$3.79$3.69-2.64%$3.81$3.6692,945 shs$103.03 million04/11/2024$3.68$3.79+2.99%$3.80$3.62178,364 shs$105.82 million04/10/2024$3.64$3.68+1.10%$3.68$3.5065,658 shs$102.75 million04/09/2024$3.63$3.64+0.28%$3.68$3.49127,711 shs$101.63 million04/08/2024$3.58$3.63+1.40%$3.64$3.4486,011 shs$101.35 million04/05/2024$3.62$3.58-1.10%$3.61$3.43143,759 shs$99.95 million04/04/2024$3.66$3.62-1.09%$3.93$3.52443,439 shs$101.07 million04/03/2024$3.47$3.66+5.48%$3.70$3.36198,968 shs$102.18 million04/02/2024$3.38$3.47+2.66%$3.48$3.26213,285 shs$96.88 million04/01/2024$3.78$3.38-10.58%$3.74$3.25424,775 shs$94.37 million03/29/2024$3.78$3.78$3.92$3.44564,540 shs$105.54 million03/28/2024$3.90$3.78-3.08%$3.92$3.44564,449 shs$105.53 million03/27/2024$3.83$3.90+1.83%$4.05$3.59642,237 shs$108.89 million03/26/2024$3.14$3.83+21.97%$4.07$3.201.53 million shs$106.93 million03/25/2024$2.89$3.14+8.65%$3.19$2.86228,365 shs$87.67 million03/22/2024$2.76$2.89+4.71%$2.90$2.67217,642 shs$80.69 million03/21/2024$2.80$2.76-1.43%$2.95$2.69384,217 shs$77.06 million03/20/2024$2.84$2.80-1.41%$2.91$2.68423,508 shs$78.18 million03/19/2024$3.08$2.84-7.79%$3.21$2.78427,943 shs$79.29 million03/18/2024$3.15$3.08-2.22%$3.35$3.02222,696 shs$85.99 millionGold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide!03/15/2024$2.89$3.15+9.00%$3.16$2.80310,479 shs$87.95 million03/14/2024$3.14$2.89-7.96%$3.12$2.81362,026 shs$80.69 million03/13/2024$3.11$3.14+0.96%$3.23$3.02193,365 shs$87.67 million03/12/2024$3.32$3.11-6.33%$3.40$3.06369,374 shs$86.83 million03/11/2024$3.50$3.32-5.14%$3.47$3.31286,423 shs$92.69 million03/08/2024$3.76$3.50-6.91%$3.81$3.32346,848 shs$97.72 million03/07/2024$3.82$3.76-1.57%$3.83$3.71127,661 shs$104.98 million03/06/2024$3.79$3.82+0.79%$3.85$3.75104,403 shs$106.65 million03/05/2024$3.80$3.79-0.26%$3.86$3.72122,248 shs$105.82 million03/04/2024$3.80$3.80$3.81$3.70133,434 shs$106.09 million03/01/2024$3.81$3.80-0.26%$3.86$3.75135,796 shs$106.10 million02/29/2024$3.87$3.81-1.55%$3.91$3.75160,513 shs$106.37 million02/28/2024$4.01$3.87-3.49%$4.09$3.80289,659 shs$108.05 million02/27/2024$4.35$4.01-7.82%$4.33$3.97516,355 shs$111.96 million02/26/2024$4.37$4.35-0.46%$4.45$4.22152,235 shs$121.45 million02/23/2024$4.33$4.37+0.92%$4.37$4.25105,239 shs$122.01 million02/22/2024$4.25$4.33+1.88%$4.33$4.20114,574 shs$120.89 million02/21/2024$4.39$4.25-3.19%$4.43$4.17112,861 shs$118.66 million02/20/2024$4.30$4.39+2.09%$4.50$4.30202,371 shs$122.57 million02/19/2024$4.30$4.30$4.35$4.20170,800 shs$120.05 million02/16/2024$4.29$4.30+0.23%$4.35$4.20170,899 shs$120.06 million02/15/2024$4.46$4.29-3.81%$4.59$4.05471,207 shs$119.77 million02/14/2024$4.70$4.46-5.11%$4.72$4.32388,868 shs$124.52 million02/13/2024$4.38$4.70+7.31%$4.82$4.36636,134 shs$131.22 million02/12/2024$4.40$4.38-0.45%$4.43$4.24218,002 shs$122.29 million02/09/2024$4.33$4.40+1.62%$4.48$4.25191,014 shs$122.85 million Related Companies: ANEB Stock Price Chart LPTX Stock Price Chart AFMD Stock Price Chart SLS Stock Price Chart TPST Stock Price Chart LFVN Stock Price Chart VTVT Stock Price Chart HOOK Stock Price Chart JAGX Stock Price Chart CRVS Stock Price Chart Receive RVPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RVPH) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.